Chemoinformaics analysis of 1,14-Tetradecanediol
| Molecular Weight | 230.392 | nRot | 13 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 0 |
| Exact Molecular Weight | 230.225 | nRing | 0 |
| Solubility: LogS | -3.289 | nHRing | 0 |
| Solubility: LogP | 3.965 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 44.9878 |
| nHD | 2 | BPOL | 30.0962 |
| QED | 0.474 |
| Synth | 1.343 |
| Natural Product Likeliness | 0.387 |
| NR-PPAR-gamma | 0.136 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.016 |
| HIA | 0.008 |
| CACO-2 | -4.68 |
| MDCK | 0.0000257 |
| BBB | 0.216 |
| PPB | 0.916353 |
| VDSS | 1.128 |
| FU | 0.0479664 |
| CYP1A2-inh | 0.556 |
| CYP1A2-sub | 0.182 |
| CYP2c19-inh | 0.238 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.184 |
| CYP2c9-sub | 0.709 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.04 |
| CYP3a4-inh | 0.066 |
| CYP3a4-sub | 0.05 |
| CL | 7.696 |
| T12 | 0.447 |
| hERG | 0.132 |
| Ames | 0.007 |
| ROA | 0.029 |
| SkinSen | 0.948 |
| Carcinogencity | 0.084 |
| EI | 0.97 |
| Respiratory | 0.172 |
| NR-Aromatase | 0.346 |
| Antiviral | Yes |
| Prediction | 0.77664 |